Failure of intravenous pentagastrin challenge to induce panic-like effects in rhesus monkeys. by Rupniak, N, Schaffer, L, Siegl, P, Iversen, S

The cholecystokinin receptor antagonist devazepide enhances morphine-induced analgesia but not morphine-induced respiratory depression in the squirrel monkey. by Dourish, C, O'Neill, M, Schaffer, L, Siegl, P, Iversen, S

Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum by Vaidya, AB, Morrisey, J, Zhang, Z, Das, S, Daly, T, Otto, T, Spillman, N, Wyvratt, M, Siegl, P, Marfurt, J, Wirjanata, G, Sebayang, B, Price, R, Chatterjee, A, Nagle, A, Stasiak, M, Charman, SA, Angulo-Barturen, I, Ferrer, S, Belén Jiménez-Díaz, M, Martínez, MS, Gamo, F, Avery, V, Ruecker, A, Delves, M, Kirk, K, Berriman, M, Kortagere, S, Burrows, J, Fan, E, Bergman, L

Quinolone-3-diarylethers: a new class of antimalarial drug. by Nilsen, A, LaCrue, A, White, K, Forquer, I, Cross, R, Marfurt, J, Mather, M, Delves, M, Shackleford, D, Saenz, F, Morrisey, J, Steuten, J, Mutka, T, Li, Y, Wirjanata, G, Ryan, E, Duffy, S, Kelly, J, Sebayang, B, Zeeman, A, Noviyanti, R, Sinden, R, Kocken, C, Price, R, Avery, V, Angulo-Barturen, I, Jiménez-Díaz, M, Ferrer, S, Herreros, E, Sanz, L, Gamo, F, Bathurst, I, Burrows, J, Siegl, P, Guy, R, Winter, R, Vaidya, AB, Charman, SA, Kyle, D, Manetsch, R, Riscoe, M

A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance. by O'Neill, P, Amewu, R, Charman, S, Sabbani, S, Gnädig, N, Straimer, J, Fidock, D, Shore, E, Roberts, N, Wong, M, Hong, W, Pidathala, C, Riley, C, Murphy, B, Aljayyoussi, G, Gamo, F, Sanz, L, Rodrigues, J, Cortes, C, Herreros, E, Angulo-Barturén, I, Jiménez-Díaz, M, Bazaga, S, Martínez-Martínez, M, Campo, B, Sharma, R, Ryan, E, Shackleford, D, Campbell, S, Smith, D, Wirjanata, G, Noviyanti, R, Price, R, Marfurt, J, Palmer, M, Copple, I, Mercer, A, Ruecker, A, Delves, M, Sinden, R, Siegl, P, Davies, J, Rochford, R, Kocken, C, Zeeman, A, Nixon, G, Biagini, G, Ward, S

UCT943, a next generation plasmodium falciparum PI4K inhibitor preclinical candidate for the treatment of malaria by Brunschwig, C, Lawrence, N, Taylor, D, Abay, E, Njoroge, M, Basarab, GS, Le Manach, C, Paquet, T, Cabrera, D, Nchinda, AT, de Kock, C, Wiesner, L, Denti, P, Waterson, D, Blasco, B, Leroy, D, Witty, MJ, Donini, C, Duffy, J, Wittlin, S, White, KL, Charman, SA, Jiménez-Díaz, MB, Angulo-Barturen, I, Herreros, E, Gamo, FJ, Rochford, R, Mancama, D, Coetzer, TL, van der Watt, ME, Reader, J, Birkholtz, L-M, Marsh, KC, Solapure, SM, Vanaerschot, M, Fidock, DA, Fish, PV, Siegl, P, Smith, DA, Wirjanata, G, Noviyanti, R, Price, RN, Marfurt, J, Silue, KD, Street, LJ, Chibale, K